🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ewa Karwatowska‐Prokopczuk

Ionis Pharmaceuticals (United States)

ORCID: 0000-0002-6371-5834

Also affiliated with Ligand Pharmaceuticals (United Kingdom), Defense Research Associates (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence–TIMI 73b trial”.

Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence–TIMI 73b trial

American Heart Journal(2025)10.1016/j.ahj.2025.02.022

N/A

0.453DataRank · unranked

12 citations

Nicholas Marston, Thomas A Prohaska, Veronica J. Alexander, André Zimerman, Filipe A. Moura +9 more

Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia

American Heart Journal(2025)10.1016/j.ahj.2025.03.003

N/A

0.408DataRank · unranked

10 citations

Brian A. Bergmark, Veronica J. Alexander, Ewa Karwatowska‐Prokopczuk, Yu Mi Kang, Filipe A. Moura +8 more

Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen

Atherosclerosis(2021)10.1016/j.atherosclerosis.2021.03.036

N/A

0DataRank · unranked

27 citations

Noémie Clouet-Foraison, Shuting Xia, Nicholas J. Viney, Joseph L. Witztum, Santica M. Marcovina +2 more